Search for: "Amerisourcebergen Corporation" Results 21 - 40 of 79
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2022, 9:41 am by David W.S. Lieberman
Cardinal Health will also enter into a compliance program, called a Corporate Integrity Agreement with the Department of Health and Human Services Office of Inspector General. [read post]
21 Jan 2022, 2:17 pm by luiza
State and local entities continued their enforcement efforts against opioid manufacturers and distributors, with mega-settlements entered into between thousands of state and local entities and drug manufacturers Johnson & Johnson and Indivior, and drug distributors McKesson Corporation, Cardinal Health Inc., and AmerisourceBergen Drug Corporation. [read post]
21 Jan 2022, 2:17 pm by luiza
State and local entities continued their enforcement efforts against opioid manufacturers and distributors, with mega-settlements entered into between thousands of state and local entities and drug manufacturers Johnson & Johnson and Indivior, and drug distributors McKesson Corporation, Cardinal Health Inc., and AmerisourceBergen Drug Corporation. [read post]
16 Dec 2021, 12:15 pm by Simmons Hanly Conroy
After six long months, the once-sprawling case has seen a number of key results in favor of plaintiffs, including: Former opioid manufacturer Allergan agreed to a $200 million settlement with New York State and Suffolk and Nassau Counties Endo Pharmaceuticals and its subsidiaries agreed to a settlement with New York State, and Suffolk and Nassau Counties, totaling $50 million Johnson & Johnson settled with the state of New York for $230 million, and as part of their agreement, the company agreed… [read post]
14 Dec 2021, 3:43 pm by Whistleblower_press
  Among the firm’s many successes is the governments’ $885 million settlement with AmerisourceBergen. [read post]
21 Oct 2021, 9:50 am by Simmons Hanly Conroy
To date, key results from the trial include: The three largest U.S. drug distributors — McKesson Corporation, Cardinal Health Inc. and AmerisourceBergen Drug Corporation — settled claims with New York State for a combined $1.18 billion Endo Pharmaceuticals and its subsidiaries agreed to a settlement with New York State, and Suffolk and Nassau Counties, totaling $50 million Johnson & Johnson settled with the state of New York for $263 million, and as part of… [read post]
16 Sep 2021, 12:57 pm by Simmons Hanly Conroy
The settlement with Endo follows recent settlements with McKesson Corporation, Cardinal Health Inc., AmerisourceBergen Drug Corporation, Walmart Inc., Rite Aid Corp, CVS Health Corp and Johnson & Johnson — bringing a total of more than $1 billion in recovered funds for New York State. [read post]
30 Jul 2021, 7:01 am by Simmons Hanly Conroy
In a major move, the third week of the ongoing New York State opioid trial saw the three largest U.S. drug distributors — McKesson Corporation, Cardinal Health Inc. and AmerisourceBergen Drug Corporation — agree mid-trial to settle claims with New York State, including both Suffolk County and Nassau County. [read post]
27 Jul 2021, 7:09 pm by Francis Pileggi
 See, e.g., AmerisourceBergen Chancery decision, highlighted here, and upheld by the “Supremes”, as noted here. [read post]
17 May 2021, 1:03 pm by Kevin LaCroix
[vii] For example, in a late 2020 decision in AmerisourceBergen Corporation v. [read post]
22 Feb 2021, 12:13 pm by Steve Bainbridge
Morris James offers a top 10 list of 2020 Delaware cases in corporate and commercial law, including a few personal favorites: AmerisourceBergen Corp. v. [read post]
16 Feb 2021, 2:23 pm by Kevin LaCroix
2020 was an eventful year in the world of corporate and securities litigation. [read post]
4 Feb 2021, 6:52 am by Kevin LaCroix
As I have noted in prior posts, there has been a recent renewed focus among observers of Delaware corporate case law development on breach of the duty of oversight claims (sometimes called Caremark claims in reference to the initial Court of Chancery decision elaborating on the duty of oversight). [read post]
29 Jan 2021, 6:01 am
Posted by the Harvard Law School Forum on Corporate Governance & Financial Regulation, on Friday, January 29, 2021 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of January 21-28, 2021. [read post]
28 Jan 2021, 6:09 pm by Francis Pileggi
This is the 16th year that Francis Pileggi has published an annual list of key corporate and commercial decisions of the Delaware Supreme Court and the Delaware Court of Chancery. [read post]
20 Jan 2021, 2:21 pm by Kevin LaCroix
Professor Shapira’s views are summarized in a January 18, 2021 post (here) on the Harvard Law School Forum on Corporate Governance. [read post]